PRAGMA-CF. A quantitative structural lung disease CT outcome in young children with cystic fibrosis

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

PRAGMA-CF. A quantitative structural lung disease CT outcome in young children with cystic fibrosis. / Rosenow, Tim; Oudraad, Merel C.J.; Murray, Conor P.; Turkovic, Lidija; Kuo, Wieying; de Bruijne, Marleen; Ranganathan, Sarath C.; Tiddens, Harm A.W.M.; Stick, Stephen M.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 191, No. 10, 2015, p. 1158-1165.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Rosenow, T, Oudraad, MCJ, Murray, CP, Turkovic, L, Kuo, W, de Bruijne, M, Ranganathan, SC, Tiddens, HAWM & Stick, SM 2015, 'PRAGMA-CF. A quantitative structural lung disease CT outcome in young children with cystic fibrosis', American Journal of Respiratory and Critical Care Medicine, vol. 191, no. 10, pp. 1158-1165. https://doi.org/10.1164/rccm.201501-0061OC

APA

Rosenow, T., Oudraad, M. C. J., Murray, C. P., Turkovic, L., Kuo, W., de Bruijne, M., Ranganathan, S. C., Tiddens, H. A. W. M., & Stick, S. M. (2015). PRAGMA-CF. A quantitative structural lung disease CT outcome in young children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine, 191(10), 1158-1165. https://doi.org/10.1164/rccm.201501-0061OC

Vancouver

Rosenow T, Oudraad MCJ, Murray CP, Turkovic L, Kuo W, de Bruijne M et al. PRAGMA-CF. A quantitative structural lung disease CT outcome in young children with cystic fibrosis. American Journal of Respiratory and Critical Care Medicine. 2015;191(10):1158-1165. https://doi.org/10.1164/rccm.201501-0061OC

Author

Rosenow, Tim ; Oudraad, Merel C.J. ; Murray, Conor P. ; Turkovic, Lidija ; Kuo, Wieying ; de Bruijne, Marleen ; Ranganathan, Sarath C. ; Tiddens, Harm A.W.M. ; Stick, Stephen M. / PRAGMA-CF. A quantitative structural lung disease CT outcome in young children with cystic fibrosis. In: American Journal of Respiratory and Critical Care Medicine. 2015 ; Vol. 191, No. 10. pp. 1158-1165.

Bibtex

@article{91cd2c83a26f4fc488c564703eee02ce,
title = "PRAGMA-CF. A quantitative structural lung disease CT outcome in young children with cystic fibrosis",
abstract = "RATIONALE: Chest computed tomography (CT) is the gold standard for demonstrating cystic fibrosis (CF) airways disease. However, there are no standardised outcome measures appropriate for children under 6 years.OBJECTIVES: We developed the Perth-Rotterdam Annotated Grid Morphometric Analysis for CF (PRAGMA-CF), a quantitative measure of airways disease, and compared it to the commonly used CF-CT scoring method.METHODS: CT scans from the Australian Respiratory Early Surveillance Team for CF (AREST CF) cohort in Western Australia were included. PRAGMA-CF was performed by annotating a grid overlaid on ten axial slices for the presence of bronchiectasis, mucous plugging or other airway abnormalities (inspiratory scans) and trapped air (expiratory scans). The separate proportions of total disease (%Dis), bronchiectasis (%Bx) and trapped air (%TA) were determined. Thirty scans were used for observer reliability, and thirty paired scans obtained at 1 and 3-years old were used for comparison with a validated standard and biological plausibility.MEASUREMENTS AND MAIN RESULTS: Intraobserver, intraclass correlation coefficients (95% confidence interval) for %Dis, %Bx and %TA were 0.93 (0.86 - 0.97), 0.93 (0.85 - 0.96) and 0.96 (0.91 - 0.98), respectively. The change in %Dis (p = 0.004) and %Bx (p = 0.001) with PRAGMA-CF was related to neutrophil elastase (NE) presence at age 3, whereas only the change in bronchiectasis score was related to NE (p < 0.001) with CF-CT. Sample size calculations for various effect sizes are presented.CONCLUSIONS: PRAGMA-CF is a sensitive and reproducible outcome measure for assessing the extent of lung disease in very young children with CF.",
author = "Tim Rosenow and Oudraad, {Merel C.J.} and Murray, {Conor P.} and Lidija Turkovic and Wieying Kuo and {de Bruijne}, Marleen and Ranganathan, {Sarath C.} and Tiddens, {Harm A.W.M.} and Stick, {Stephen M.}",
year = "2015",
doi = "10.1164/rccm.201501-0061OC",
language = "English",
volume = "191",
pages = "1158--1165",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "10",

}

RIS

TY - JOUR

T1 - PRAGMA-CF. A quantitative structural lung disease CT outcome in young children with cystic fibrosis

AU - Rosenow, Tim

AU - Oudraad, Merel C.J.

AU - Murray, Conor P.

AU - Turkovic, Lidija

AU - Kuo, Wieying

AU - de Bruijne, Marleen

AU - Ranganathan, Sarath C.

AU - Tiddens, Harm A.W.M.

AU - Stick, Stephen M.

PY - 2015

Y1 - 2015

N2 - RATIONALE: Chest computed tomography (CT) is the gold standard for demonstrating cystic fibrosis (CF) airways disease. However, there are no standardised outcome measures appropriate for children under 6 years.OBJECTIVES: We developed the Perth-Rotterdam Annotated Grid Morphometric Analysis for CF (PRAGMA-CF), a quantitative measure of airways disease, and compared it to the commonly used CF-CT scoring method.METHODS: CT scans from the Australian Respiratory Early Surveillance Team for CF (AREST CF) cohort in Western Australia were included. PRAGMA-CF was performed by annotating a grid overlaid on ten axial slices for the presence of bronchiectasis, mucous plugging or other airway abnormalities (inspiratory scans) and trapped air (expiratory scans). The separate proportions of total disease (%Dis), bronchiectasis (%Bx) and trapped air (%TA) were determined. Thirty scans were used for observer reliability, and thirty paired scans obtained at 1 and 3-years old were used for comparison with a validated standard and biological plausibility.MEASUREMENTS AND MAIN RESULTS: Intraobserver, intraclass correlation coefficients (95% confidence interval) for %Dis, %Bx and %TA were 0.93 (0.86 - 0.97), 0.93 (0.85 - 0.96) and 0.96 (0.91 - 0.98), respectively. The change in %Dis (p = 0.004) and %Bx (p = 0.001) with PRAGMA-CF was related to neutrophil elastase (NE) presence at age 3, whereas only the change in bronchiectasis score was related to NE (p < 0.001) with CF-CT. Sample size calculations for various effect sizes are presented.CONCLUSIONS: PRAGMA-CF is a sensitive and reproducible outcome measure for assessing the extent of lung disease in very young children with CF.

AB - RATIONALE: Chest computed tomography (CT) is the gold standard for demonstrating cystic fibrosis (CF) airways disease. However, there are no standardised outcome measures appropriate for children under 6 years.OBJECTIVES: We developed the Perth-Rotterdam Annotated Grid Morphometric Analysis for CF (PRAGMA-CF), a quantitative measure of airways disease, and compared it to the commonly used CF-CT scoring method.METHODS: CT scans from the Australian Respiratory Early Surveillance Team for CF (AREST CF) cohort in Western Australia were included. PRAGMA-CF was performed by annotating a grid overlaid on ten axial slices for the presence of bronchiectasis, mucous plugging or other airway abnormalities (inspiratory scans) and trapped air (expiratory scans). The separate proportions of total disease (%Dis), bronchiectasis (%Bx) and trapped air (%TA) were determined. Thirty scans were used for observer reliability, and thirty paired scans obtained at 1 and 3-years old were used for comparison with a validated standard and biological plausibility.MEASUREMENTS AND MAIN RESULTS: Intraobserver, intraclass correlation coefficients (95% confidence interval) for %Dis, %Bx and %TA were 0.93 (0.86 - 0.97), 0.93 (0.85 - 0.96) and 0.96 (0.91 - 0.98), respectively. The change in %Dis (p = 0.004) and %Bx (p = 0.001) with PRAGMA-CF was related to neutrophil elastase (NE) presence at age 3, whereas only the change in bronchiectasis score was related to NE (p < 0.001) with CF-CT. Sample size calculations for various effect sizes are presented.CONCLUSIONS: PRAGMA-CF is a sensitive and reproducible outcome measure for assessing the extent of lung disease in very young children with CF.

U2 - 10.1164/rccm.201501-0061OC

DO - 10.1164/rccm.201501-0061OC

M3 - Journal article

C2 - 25756857

VL - 191

SP - 1158

EP - 1165

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 10

ER -

ID: 136058018